In vitro anthracycline cross-resistance pattern in childhood acute lymphoblastic leukaemia.

Daunorubicin (DNR) is a major front-line drug in the treatment of childhood acute lymphoblastic leukaemia (ALL). Previously, we showed that in vitro resistance to DNR at diagnosis is related to a poor long-term clinical outcome in childhood ALL and that relapsed ALL samples are more resistant to DNR...

Descripción completa

Detalles Bibliográficos
Autores principales: Klumper, E., Pieters, R., den Boer, M. L., Huismans, D. R., Loonen, A. H., Veerman, A. J.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1995
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033825/
https://www.ncbi.nlm.nih.gov/pubmed/7779709

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033825/
https://www.ncbi.nlm.nih.gov/pubmed/7779709

Ejemplares similares